ResearcherJiaxing UniversityActive in the last 2 years

Lingyu Hu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108949802. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis. First author DOI 10.1186/s12876-024-03581-5 ↗
Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics. Co-author DOI 10.1186/s10020-024-00996-4 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiaoguang Wang · 1 shared paper, 2025 · strength 0.30
- Paper The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor c… DOI 10.1186/s12876-024-03581-5 ↗
Xiaorong Liu · 1 shared paper, 2025 · strength 0.30
- Paper The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor c… DOI 10.1186/s12876-024-03581-5 ↗
Wei Guo · 1 shared paper, 2025 · strength 0.30
- Paper The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor c… DOI 10.1186/s12876-024-03581-5 ↗
Fei Chen · 1 shared paper, 2024 · strength 0.28
- Paper Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell … DOI 10.1186/s10020-024-00996-4 ↗
Zhengwei Song · 1 shared paper, 2024 · strength 0.28
- Paper Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell … DOI 10.1186/s10020-024-00996-4 ↗
Bin Yan Wu · 1 shared paper, 2024 · strength 0.28
- Paper Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell … DOI 10.1186/s10020-024-00996-4 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.